Completed OBSERVATIONAL NCT03290105

Microbial and Pharmacological Assessment of Chlorhexidine

Efficacy of Chlorhexidine Mouth Wash in ICU Ventilated Patients: Microbiological Effects and Antiseptic Residual Concentrations

Sponsor: Hôpital Louis Mourier

Conditions Bacterium; Agent Chlorhexidine Infection, Bacterial Oropharynx Abnormality Pneumonia, Ventilator-Associated

Updated 9 times since 2017 Last updated: Sep 21, 2017 Started: Jan 27, 2014 Primary completion: Mar 31, 2014 Completion: Jun 1, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03290105, this observational or N/A phase trial focuses on Bacterium; Agent and Chlorhexidine and remains completed. Sponsored by Hôpital Louis Mourier, it has been updated 9 times since 2014, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hôpital Louis Mourier

Data source: Hôpital Louis Mourier

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.